Novel Neuropathological Features of a Child with an Epileptic Encephalopathy Due to Presumed Polyol Dysmetabolism

Abstract

Disorders of carbohydrate metabolism resulting in accumulation of polyols in body fluids were first described in the early 1990s by van der Knapp et al, but this diagnosis remains rare with very few patients reported with primary neurological phenotypes. We present a child with a presumed polyol disorder whose clinical course was similar to two of the original five patients and who had similar findings in quantification of urinary polyols. In addition, we document details of central nervous system pathology in this rare metabolic disorder. The basic pathology is that of a neurodegenerative disorder with hypomyelination leukodystrophy consequent to a defect of oligodendroglia and resultant axonal and neuronal loss.

Keywords

polyol disorder - epileptic encephalopathy - pathology

^* Dr. Gonatas is deceased.

• References

• 1 O'Brien MM, Schofield PJ, Edwards MR. Polyol-pathway enzymes of human brain. Partial purification and properties of sorbitol dehydrogenase. Biochem J 1983; 211 (01) 81-90
• 2 Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol 2001; 18 (04) 247-256
• 3 Demirbas D, Coelho AI, Rubio-Gozalbo ME, Berry GT. Hereditary galactosemia. Metabolism 2018; 83: 188-196
• 4 Vaca G, Ibarra B, Bracamontes M. , et al. Red blood cell sorbitol dehydrogenase deficiency in a family with cataracts. Hum Genet 1982; 61 (04) 338-341
• 5 Wamelink MM, Ramos RJ, van den Elzen AP. , et al. First two unrelated cases of isolated sedoheptulokinase deficiency: a benign disorder?. J Inherit Metab Dis 2015; 38 (05) 889-894
• 6 Onkenhout W, Groener JE, Verhoeven NM, Yin C, Laan LA. L-Arabinosuria: a new defect in human pentose metabolism. Mol Genet Metab 2002; 77 (1–2): 80-85
• 7 Verhoeven NM, Wallot M, Huck JH. , et al. A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency. J Inherit Metab Dis 2005; 28 (02) 169-179
• 8 Huck JH, Verhoeven NM, Struys EA, Salomons GS, Jakobs C, van der Knaap MS. Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy. Am J Hum Genet 2004; 74 (04) 745-751
• 9 Cooper ME. Pathogenesis, prevention, and treatment of diabetic nephropathy. Lancet 1998; 352 (9123): 213-219
• 10 Lee AY, Chung SK, Chung SS. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc Natl Acad Sci U S A 1995; 92 (07) 2780-2784
• 11 Regenold WT, Phatak P, Makley MJ, Stone RD, Kling MA. Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression. J Neurol Sci 2008; 275 (1-2): 106-112
• 12 Berry GT. The role of polyols in the pathophysiology of hypergalactosemia. Eur J Pediatr 1995; 154 (07) (Suppl. 02) S53-S64
• 13 Shetty HU, Schapiro MB, Holloway HW, Rapoport SI. Polyol profiles in Down syndrome. myo-inositol, specifically, is elevated in the cerebrospinal fluid. J Clin Invest 1995; 95 (02) 542-546
• 14 Regenold WT, Hisley KC, Obuchowski A, Lefkowitz DM, Marano C, Hauser P. Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients. J Affect Disord 2005; 85 (03) 341-350
• 15 Moolenaar SH, van der Knaap MS, Engelke UF. , et al. In vivo and in vitro NMR spectroscopy reveal a putative novel inborn error involving polyol metabolism. NMR Biomed 2001; 14 (03) 167-176
• 16 Huck JH, Verhoeven NM, van Hagen JM, Jakobs C, van der Knaap MS. Clinical presentations of patients with polyol abnormalities. Neuropediatrics 2004; 35 (03) 167-173
• 17 van der Knaap MS, Wevers RA, Struys EA. , et al. Leukoencephalopathy associated with a disturbance in the metabolism of polyols. Ann Neurol 1999; 46 (06) 925-928
• 18 Schiffmann R, van der Knaap MS. Invited article: an MRI-based approach to the diagnosis of white matter disorders. Neurology 2009; 72 (08) 750-759
• 19 Costello DJ, Eichler AF, Eichler FS. Leukodystrophies: classification, diagnosis, and treatment. Neurologist 2009; 15 (06) 319-328
• 20 Mar S, Noetzel M. Axonal damage in leukodystrophies. Pediatr Neurol 2010; 42 (04) 239-242
• 21 Bugiani M, Boor I, van Kollenburg B. , et al. Defective glial maturation in vanishing white matter disease. J Neuropathol Exp Neurol 2011; 70 (01) 69-82
• 22 Forcier NJ, Mizisin AP, Rimmer MA, Powell HC. Cellular pathology of the nerve microenvironment in galactose intoxication. J Neuropathol Exp Neurol 1991; 50 (03) 235-255